ACC.24 - In the PREVENT trial, preventive PCI plus optimal medical therapy (OMT) was superior to OMT alone for reducing cardiac events in patients with non–flow-limiting vulnerable coronary plaques. Marc Bonaca, the discussant of the PREVENT trial, reviews the results.
Preventive PCI versus optimal medical therapy only for vulnerable plaques
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Marc Bonaca, MD is a Cardiologist and Vascular Medicine Specialist and is the Executive Director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 15 april 2024
Recommended
Details
Presenters
Overview
ACC.24 - In the PREVENT trial, preventive PCI plus optimal medical therapy (OMT) was superior to OMT alone for reducing cardiac events in patients with non–flow-limiting vulnerable coronary plaques. Marc Bonaca, the discussant of the PREVENT trial, reviews the results.
Educational information
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
Faculty
Marc Bonaca, MD is a Cardiologist and Vascular Medicine Specialist and is the Executive Director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 15 april 2024
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
1.00 credits
<p>Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring</p>
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
MinuteCE®
CETP inhibition: Lessons from two decades of clinical trials
0.50 credits
<p><span data-contrast="none" style="list-style-type: disc;" xml:lang="EN-US">CETP inhibition: Lessons from two decades of clinical trials</span></p>
NeuroFrontiers
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
<p>Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms</p>
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
<p>mIDH Gliomas Explained: Characteristics and Management Strategies</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?